J&J/DePuy Spine launches Healos Fx
This article was originally published in The Gray Sheet
Executive Summary
Injectable bone graft replacement designed specifically for minimally invasive spine surgery debuts April 27. The 510(k)-cleared Healos Fx is a ready-to-use fibrous material that can be molded for open applications or "injected via cannulas of differing lengths to reach difficult implantation sites in minimally invasive or small void surgical environments," the firm states. When saturated with a patient's bone marrow, Healos Fx serves as a continuous scaffold for bone formation and the osteoprogenitor cells needed to initiate new bone growth, according to the company. Healos in strip form has been available in the U.S. for over seven years, the firm notes